The Elizabeth Taylor AIDS Foundation (ETAF) announced today its second annual New York Dinner will take place on May 8, 2024 at the legendary Rainbow Room on the 65th floor of Rockefeller Plaza. The evening will honor Arthur Fogel, President, Global Touring and Chairman, Concerts at Live Nation Entertainment with The Elizabeth Taylor Commitment to End AIDS Award for his support to end the HIV epidemic.
LOS ANGELES, CA – February 8, 2024 — The Elizabeth Taylor AIDS Foundation (ETAF) announced today its second annual New York Dinner will take place on May 8, 2024 at the legendary Rainbow Room on the 65th floor of Rockefeller Plaza. Generously supported by Presenting Sponsor Gilead Sciences, Inc., the evening will honor Arthur Fogel, President, Global Touring and Chairman, Concerts at Live Nation Entertainment with The Elizabeth Taylor Commitment to End AIDS Award for his support to end the HIV epidemic.
The New York Dinner will include an intimate reception, seated dinner and program, and live performance. As one of the most visible annual events for ETAF, the proceeds from the evening will continue the work toward Elizabeth Taylor’s vision of an AIDS-free world.
“Thank you to the Elizabeth Taylor AIDS Foundation. I am honored and humbled to receive this award and I look forward to a great event to support the Foundation,” said Fogel.
For more information please contact in**@et**.org.
ABOUT ETAF
Working tirelessly on the AIDS crisis throughout the 1980s, Elizabeth Taylor established The Elizabeth Taylor AIDS Foundation (ETAF) in 1991 to carry out her vision for an AIDS-free world. ETAF works to provide the direct care needed for people living with and affected by HIV and AIDS. Emphasizing Elizabeth’s voice, commitment, and concentration on hard-to-reach communities, ETAF’s domestic advocacy initiatives remain a priority. Fighting for criminalization reform for people living with HIV, ETAF’s primary advocacy initiative, “HIV Is Not A Crime” fights for not only the elimination of criminalization, but also stigma and discrimination. ETAF’s programs have also expanded to ensure that HIV prevention education and access to treatment are available through domestic and international initiatives.
ABOUT GILEAD SCIENCES
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, inflammation and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
CONTACTS:
